Synthesis and biological activity of novel 4,4-difluorobenzazepine derivatives as non-peptide antagonists of the arginine vasopressin V1A receptor
- 11 November 2005
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 14 (6) , 1827-1837
- https://doi.org/10.1016/j.bmc.2005.10.035
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptorsPharmacological Research, 2005
- Stereoselective Synthesis of Methyl (Z)-(4,4-Difluoro-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylidene)acetate Using a Dianion Horner-Wadsworth-Emmons ReagentCHEMICAL & PHARMACEUTICAL BULLETIN, 2005
- Synthesis and Structure−Activity Relationships of 5,6,7,8-Tetrahydro-4H-thieno[3,2-b]azepine Derivatives: Novel Arginine Vasopressin AntagonistsJournal of Medicinal Chemistry, 2003
- Synthesis and Pharmacological Evaluation of 5-(4-Biphenyl)-3-methyl-4-phenyl-1,2,4-triazole Derivatives as a Novel Class of Selective Antagonists for the Human Vasopressin V1A ReceptorJournal of Medicinal Chemistry, 2002
- The Protein Data BankNucleic Acids Research, 2000
- Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cellsBritish Journal of Pharmacology, 1998
- Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogsEuropean Journal of Pharmacology, 1997
- Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihydro-2(1H)-quinolinonesJournal of Medicinal Chemistry, 1993
- Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.Journal of Clinical Investigation, 1993
- OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor AntagonistScience, 1991